Sientra (NASDAQ:SIEN) Stock Rating Upgraded by StockNews.com

Sientra (NASDAQ:SIENGet Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Saturday.

Other research analysts also recently issued reports about the stock. Canaccord Genuity Group cut their price objective on shares of Sientra from $10.00 to $8.00 and set a “buy” rating for the company in a report on Tuesday, March 29th. Colliers Securities reiterated a “buy” rating on shares of Sientra in a research note on Tuesday, March 22nd. UBS Group lowered their target price on shares of Sientra from $10.00 to $8.00 and set a “buy” rating on the stock in a research note on Tuesday, March 29th. Zacks Investment Research cut shares of Sientra from a “hold” rating to a “sell” rating in a research report on Tuesday, March 29th. Finally, Lake Street Capital assumed coverage on shares of Sientra in a research report on Thursday, April 14th. They set a “buy” rating and a $8.00 price objective on the stock. One analyst has rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Sientra presently has a consensus rating of “Buy” and an average target price of $7.75.

Shares of Sientra stock opened at $1.42 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.76 and a debt-to-equity ratio of 1.53. Sientra has a twelve month low of $1.25 and a twelve month high of $9.14. The stock has a market cap of $88.56 million, a price-to-earnings ratio of -0.83 and a beta of 1.99. The company’s fifty day moving average is $2.21 and its 200 day moving average is $3.41.

Sientra (NASDAQ:SIENGet Rating) last announced its quarterly earnings data on Wednesday, March 23rd. The medical instruments supplier reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.08). The company had revenue of $22.65 million for the quarter, compared to analyst estimates of $22.50 million. Sientra had a negative net margin of 112.89% and a negative return on equity of 865.36%. During the same quarter in the prior year, the company posted ($0.38) EPS. As a group, equities analysts anticipate that Sientra will post -0.88 earnings per share for the current fiscal year.

A number of large investors have recently modified their holdings of the stock. BlackRock Inc. raised its position in Sientra by 1.8% in the 4th quarter. BlackRock Inc. now owns 3,693,642 shares of the medical instruments supplier’s stock worth $13,556,000 after purchasing an additional 66,003 shares during the period. Morgan Stanley grew its holdings in Sientra by 11.2% in the 3rd quarter. Morgan Stanley now owns 3,117,077 shares of the medical instruments supplier’s stock worth $17,861,000 after acquiring an additional 314,815 shares during the last quarter. Senvest Management LLC grew its holdings in Sientra by 8.1% in the 4th quarter. Senvest Management LLC now owns 2,861,039 shares of the medical instruments supplier’s stock worth $10,500,000 after acquiring an additional 215,000 shares during the last quarter. Schroder Investment Management Group grew its holdings in Sientra by 3.0% in the 4th quarter. Schroder Investment Management Group now owns 2,837,877 shares of the medical instruments supplier’s stock worth $10,415,000 after acquiring an additional 81,659 shares during the last quarter. Finally, Bamco Inc. NY grew its holdings in Sientra by 9.0% in the 3rd quarter. Bamco Inc. NY now owns 2,578,364 shares of the medical instruments supplier’s stock worth $14,774,000 after acquiring an additional 213,001 shares during the last quarter. Institutional investors own 89.48% of the company’s stock.

About Sientra (Get Rating)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Read More

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.